Neumora Therapeutics, Inc. (NMRA)
Market Closed
4 Sep, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
1. 31
-0.04
-2.963%
$
246.43M Market Cap
- P/E Ratio
- Div Yield
547,000 Volume
-1.75 Eps
$ 1.35
Previous Close 
Want to track NMRA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Neumora Therapeutics, Inc. (NMRA) Statistics
Valuation metrics
Market Cap 246.43M
Enterprise value 126.23M
Trailing P/E (ttm) -1.07
Forward P/E -
PEG ratio -0.04
Price/Sales (ttm) -
Price/Book (mrq) 5.45
Enterprise Value/Revenue -
Enterprise Value/EBITDA -0.61
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 497.7K
Average volume (90 days) 3.2M
Price summary
52-Week low 0.83
52-Week high 3.65
Beta -
50-Day moving average 1.53
200-Day moving average 2.38
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -
Operating margin -
Operational effectiveness
Return on assets -1.7%
Return on equity -2.42%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) -
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -1.15
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.63
Total debt (mrq) -
Total Debt/Equity (mrq) 0.01
Current ratio (mrq) 4.5%
Book value per share (mrq) 0.24
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
